Julie Vose, M.D., University of Nebraska Medical Center oncologist,
recently was named chief of the section of hematology/oncology, UNMC Department
of Internal Medicine, following an extensive national search. Dr. Vose
succeeds Ken Cowan, M.D., Ph.D., who served as interim section chief the
past two years. Prior to that, Anne Kessinger, M.D., UNMC oncologist, served
as section chief for eight years.
The section consists of nearly 70 faculty, staff and fellows, whose
goal is to support the UNMC/Nebraska Health System adult cancer program
through cancer diagnosis, treatment, research and education.
We are extraordinarily lucky to have attracted her to this position,
said James Armitage, M.D., oncologist and dean of the UNMC College of Medicine
whose association with Dr. Vose began when she was a medical student. She
will serve as an outstanding role model and leader.
I believe that Dr. Vose will be an outstanding leader in this capacity,
said John L. Gollan, M.D., Ph.D., Henry J. Lehnhoff Professor and Chairman,
UNMC Department of Internal Medicine. Her vision for the development of
clinical oncology services, in partnership with the Nebraska Health System,
and for the expansion of oncology research and education will further enhance
the quality and identity of this key program.
Dr. Vose, who is considered one of the country’s leading experts on
lymphoma, currently is principal investigator or co-investigator for clinical
research grants totaling more than $6 million. One of her research efforts
focuses on tailor-made cancer vaccines for patient’s with lymphoma. UNMC
is one of 23 cancer centers in the United States studying this promising
therapy.
The appointment is an honor for me, Dr. Vose said. After being at
UNMC for the past 23 years, I have seen it grow and expand into a modern
cancer center with the ability for us to administer many novel treatments
for our patients and to interact with scientists in translational research
for the next generation of agents. My goals are to add several new clinical
and research faculty in the areas of breast, gastrointestinal, head and
neck and lung cancer as well as bone marrow and stem cell transplantation.
We want to expand the interactions between the clinical and basic scientists
to bring new discoveries to the clinic to improve the care for our patients,
she said. The part of my work that is the most gratifying is when we have
patients that come to us from all over the United States to receive new
therapies. They often complement us on the personalized care they receive
here, which they appreciate as well as the opportunity to receive new therapies
they could not get at home. I am always happy when they recover from
their treatments and are able to return to their family and friends.
Dr. Vose graduate in 1978 with a bachelors degree from South Dakota
State University, then graduated from UNMCs medical technology program
with distinction in 1979. In 1984, she earned her medical degree from UNMC
then did her residency in internal medicine at UNMC from 1984 to 87. She
served as chief resident from 1987 to 1988 and then served a fellowship
in oncology/hematology from 1988 to 1990 at UNMC.
Dr. Vose was named assistant professor in 1990, associate professor
in 1994 and professor in 1998. She served as vice chairman of the department
of internal medicine from 1997 to 1999.
Board-certified in internal medicine, medical oncology and hematology,
Dr. Vose is co-director of the Nebraska Lymphoma Study Group and chair
of the North American Bone Marrow Transplant Registry. She currently is
editor of the Leukemia and Lymphoma journal and has served on various cancer
publications editorial boards.
Some of the awards Dr. Vose has received include the UNMC Department
of Internal Medicine Clinical Research Award (2000), the Lymphoma Research
Foundations Evelyn Hoffman Memorial Award for Excellence in Lymphoma Research
(2000), UNMC Young Investigator Award Recipient (1994), Michael Horbach
Award for Student Excellence in Hematology (1984) and American Cancer Society
Clinical Oncology Fellowship (1988 and 1989).
Dr. Vose is currently a member of the American Society of Clinical Oncology,
the American Society of Hematology, the International Society of Experimental
Hematology, and the American Association of Cancer Research. Shes authored
or co-authored 161 manuscripts, 34 book chapters and 176 abstracts, and
has given more than 300 lectures and presentations internationally in her
field of expertise.